Victor Clavelli has been appointed chief commercial officer of Optinose (NASDAQ: [[ticker:OPTN]]). He joins the Yardley, PA-based company from Pfizer (NYSE: [[ticker:PFE]]), where he was most recently the company’s North American president for inflammation and immunology. Optinose develops and sells products addressing conditions of the ear, nose, and throat.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
